Ji-Ming Zhang (J Zhang, Jiming Zhang)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 36

Top Topics

Hepatitis B Virus

Prognostic Factors

Ejection Fraction

Top Venues

Journal of viral hepatitis

Alimentary pharmacology & therapeutics

Canadian journal of gastroenterology & hepatology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Xue-Ping Yu, Feifei Yang, Zhongliang Shen, Yao Zhang, Jian Sun, Chao Qiu, Yijuan Zheng, Weidong Zhao, Songhua Yuan, Dawu Zeng, Shenyan Zhang, Jianfei Long, Mengqi Zhu, Xueyun Zhang, Jingwen Wu, Zhenxuan Ma, Haoxiang Zhu, Milong Su, Jianqing Xu, Bin Li, Ri-Cheng Mao, Zhijun Su, Ji-Ming Zhang
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4 + T-cell exhaustion. Nature communications 15 (1) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics (2024)
Xue-Ping Yu, Feifei Yang, Zhongliang Shen, Yao Zhang, Jian Sun, Chao Qiu, Yijuan Zheng, Weidong Zhao, Songhua Yuan, Dawu Zeng, Shenyan Zhang, Jianfei Long, Mengqi Zhu, Xueyun Zhang, Jingwen Wu, Zhenxuan Ma, Haoxiang Zhu, Milong Su, Jianqing Xu, Bin Li, Ri-Cheng Mao, Zhijun Su, Ji-Ming Zhang
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4 + T-cell exhaustion. Nature communications 15 (1) (2024)
Xue-Ping Yu, Feifei Yang, Zhongliang Shen, Yao Zhang, Jian Sun, Chao Qiu, Yijuan Zheng, Weidong Zhao, Songhua Yuan, Dawu Zeng, Shenyan Zhang, Jianfei Long, Mengqi Zhu, Xueyun Zhang, Jingwen Wu, Zhenxuan Ma, Haoxiang Zhu, Milong Su, Jianqing Xu, Bin Li, Ri-Cheng Mao, Zhijun Su, Ji-Ming Zhang
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4 + T-cell exhaustion. Nature communications 15 (1) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Na-Ling Kang, Lu-Ying Wu, Qi Zheng, Xue-Ping Yu, Ai-Rong Hu, Yue Guo, Huan Li, Xiang-Yang Ye, Qing-Fa Ruan, Zhong-Hua Lu, Ling Wu, Wen Jin, Yu-Rui Liu, Chen Pan, Shan-Shan Liu, Ji-Ming Zhang, Jia-Ji Jiang, Da-Wu Zeng
Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (5) (2024)
Xue-Ping Yu, Feifei Yang, Zhongliang Shen, Yao Zhang, Jian Sun, Chao Qiu, Yijuan Zheng, Weidong Zhao, Songhua Yuan, Dawu Zeng, Shenyan Zhang, Jianfei Long, Mengqi Zhu, Xueyun Zhang, Jingwen Wu, Zhenxuan Ma, Haoxiang Zhu, Milong Su, Jianqing Xu, Bin Li, Ri-Cheng Mao, Zhijun Su, Ji-Ming Zhang
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4 + T-cell exhaustion. Nature communications 15 (1) (2024)
Tong Yu, Miaoqu Zhang, Hanyue Zhang, Jianming Zheng, Chuan Shen, Ning Jiang, Lei Zou, Jing Wang, Yiqi Yu, Qiran Zhang, Shuili Yu, Yanfang Huang, Yuxian Huang, Ji-Ming Zhang, Chao Qiu, Wenhong Zhang, Zhefeng Meng
Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues. The Journal of infectious diseases 227 (5) (2023)
Yao Zhang, Xueyun Zhang, Jiajia Han, Yifei Guo, Jingjing He, Feifei Yang, Ri-Cheng Mao, Yu-Xian Huang, Ji-Ming Zhang
Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Canadian journal of gastroenterology & hepatology 2023 (2023)
Xiongyue Cao, Qiankun Hu, Wei Xu, Qiang Li, Ji-Ming Zhang, Liang Chen, Yuxian Huang, Xun Qi
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfa. Journal of viral hepatitis 30 (4) (2023)
Xiongyue Cao, Qiankun Hu, Wei Xu, Qiang Li, Ji-Ming Zhang, Liang Chen, Yuxian Huang, Xun Qi
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfa. Journal of viral hepatitis 30 (4) (2023)
Yao Zhang, Xueyun Zhang, Jiajia Han, Yifei Guo, Feifei Yang, Fahong Li, Haoxiang Zhu, Zhongliang Shen, Yuxian Huang, Richeng Mao, Ji-Ming Zhang
Downregulated VISTA enhances Th17 differentiation and aggravates inflammation in patients with acute-on-chronic liver failure. Hepatology international (2023)
Xiongyue Cao, Qiankun Hu, Wei Xu, Qiang Li, Ji-Ming Zhang, Liang Chen, Yuxian Huang, Xun Qi
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfa. Journal of viral hepatitis 30 (4) (2023)
Tong Yu, Miaoqu Zhang, Hanyue Zhang, Jianming Zheng, Chuan Shen, Ning Jiang, Lei Zou, Jing Wang, Yiqi Yu, Qiran Zhang, Shuili Yu, Yanfang Huang, Yuxian Huang, Ji-Ming Zhang, Chao Qiu, Wenhong Zhang, Zhefeng Meng
Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues. The Journal of infectious diseases 227 (5) (2023)
Zhongliang Shen, Jingwen Wu, Zixiang Gao, Shenyan Zhang, Jingwen Chen, Jingjing He, Yifei Guo, Qiang Deng, Youhua Xie, Jing Liu, Ji-Ming Zhang
High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein. Nucleic acids research 50 (4) (2022)
Yao Zhang, Jiajia Han, Xueyun Zhang, Fahong Li, Yifei Guo, Jingjing He, Richeng Mao, Haoxiang Zhu, Jie Yu, Yuxian Huang, Feifei Yang, Ji-Ming Zhang
Lower frequency of MDSCs was significantly related to functional cure in CHB patients treated with peginterferon. Liver international : official journal of the International Association for the Study of the Liver (2022)
Yiran Xie, Haoxiang Zhu, Yifei Guo, Zhenxuan Ma, Xun Qi, Feifei Yang, Ri-Cheng Mao, Ji-Ming Zhang
Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study. Canadian journal of gastroenterology & hepatology 2022 (2022)
Xiongyue Cao, Qiankun Hu, Wei Xu, Qiang Li, Ji-Ming Zhang, Liang Chen, Yuxian Huang, Xun Qi
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfa. Journal of viral hepatitis (2022)
Tong Yu, Miaoqu Zhang, Hanyue Zhang, Jianming Zheng, Chuan Shen, Ning Jiang, Lei Zou, Jing Wang, Yiqi Yu, Qiran Zhang, Shuili Yu, Yanfang Huang, Yuxian Huang, Ji-Ming Zhang, Chao Qiu, Wenhong Zhang, Zhefeng Meng
Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated with Nucleos(t)ide Analogues. The Journal of infectious diseases (2022)
Zhenxuan Ma, Yanli Qin, Yidi Jia, Yiran Xie, Xun Qi, Yifei Guo, Jingjing He, Yongmei Zhang, Fahong Li, Jie Yu, Haoxiang Zhu, Feifei Yang, Yu Zhang, Richeng Mao, Ji-Ming Zhang
Thyroid dysfunction incidence and risk factors in Chinese chronic hepatitis B patients treated with pegylated interferon alpha: A long-term follow-up study. Journal of viral hepatitis 29 (6) (2022)
Fahong Li, Yingying Deng, Shenyan Zhang, Beidi Zhu, Jun Wang, Jinyu Wang, Xueyu Wang, Zhenyu Zhao, Wanyu Deng, Richeng Mao, Zhongliang Shen, Jieliang Chen, Ruth Broering, Yong Lin, Mengji Lu, Ji-Ming Zhang
Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines. Emerging microbes & infections 11 (1) (2022)
Xiongyue Cao, Qiankun Hu, Wei Xu, Qiang Li, Ji-Ming Zhang, Liang Chen, Yuxian Huang, Xun Qi
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfa. Journal of viral hepatitis (2022)
Yiran Xie, Haoxiang Zhu, Yifei Guo, Zhenxuan Ma, Xun Qi, Feifei Yang, Ri-Cheng Mao, Ji-Ming Zhang
Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study. Canadian journal of gastroenterology & hepatology 2022 (2022)
Yiran Xie, Haoxiang Zhu, Yifei Guo, Zhenxuan Ma, Xun Qi, Feifei Yang, Ri-Cheng Mao, Ji-Ming Zhang
Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study. Canadian journal of gastroenterology & hepatology 2022 (2022)
Xueyun Zhang, Yao Zhang, Pu Zhou, Jingwen Ai, Xiaoqin Liu, Quanbao Zhang, Zhengxin Wang, Hongyan Wang, Wenhong Zhang, Ji-Ming Zhang, Yu-Xian Huang
Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients. Emerging microbes & infections 11 (1) (2022)
Yiran Xie, Haoxiang Zhu, Yifei Guo, Zhenxuan Ma, Xun Qi, Feifei Yang, Ri-Cheng Mao, Ji-Ming Zhang
Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study. Canadian journal of gastroenterology & hepatology 2022 (2022)
Ning Li, Kangkang Yu, Minhui Dong, Jinyu Wang, Feifei Yang, Haoxiang Zhu, Jie Yu, Jingshu Yang, Wentao Xie, Bidisha Mitra, Richeng Mao, Feizhen Wu, Haitao Guo, Ji-Ming Zhang
Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy. Emerging microbes & infections 11 (1) (2022)
Qiankun Hu, Xun Qi, Yiqi Yu, Yueqiu Gao, Xin-Xin Zhang, Qianqian Wang, Xueyun Zhang, Yunhui Zhuo, Jing Li, Ji-Ming Zhang, Liang Chen, Yu-Xian Huang
The efficacy and safety of adding on or switching to peginterferon α-2b in HBeAg-positive chronic hepatitis B patients with long-term entecavir treatment: a multicentre randomised controlled trial. Alimentary pharmacology & therapeutics 56 (9) (2022)
Jian Sun, Hongying Guo, Xueping Yu, Haoxiang Zhu, Xueyun Zhang, Jianghua Yang, Jiefei Wang, Zhiping Qian, Zhongliang Shen, Richeng Mao, Ji-Ming Zhang
A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure. BMC gastroenterology 21 (1) (2021)
Jing Li, Lihong Qu, Xuehua Sun, Yanhong Liu, Qiming Gong, Demin Yu, Donghua Zhang, Jiehong Jiang, Jia Chen, Dong Wei, Yue Han, Yueqiu Gao, Qin Zhang, Weimin She, Liang Chen, Ji-Ming Zhang, Xinxin Zhang
Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naïve patients. Journal of viral hepatitis 28 (10) (2021)
Jing Li, Jisu Li, Shiqi Chen, Quan Yuan, Jing Zhang, Jingwen Wu, Qirong Jiang, Qianru Wang, Ning-Shao Xia, Ji-Ming Zhang, Shuping Tong
Naturally occurring 5' preS1 deletions markedly enhance replication and infectivity of HBV genotype B and genotype C. Gut 70 (3) (2020)
Hong-Ying Guo, Beidi Zhu, Shu Li, Jing Li, Zhiqing Shen, Yijuan Zheng, Weidong Zhao, Dan Tan, Jingwen Wu, Xueyun Zhang, Qirong Jiang, Xun Qi, Richeng Mao, Xue-Ping Yu, Zhijun Su, Ji-Ming Zhang
Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B. BioMed research international 2019 (2019)
J Wang, Y Yu, G Li, C Shen, J Li, S Chen, X Zhang, M Zhu, J Zheng, Z Song, J Wu, L Shao, Z Meng, Xuan-Yi Wang, Y Huang, Ji-Ming Zhang, C Qiu, W Zhang
Natural history of serum HBV-RNA in chronic HBV infection. Journal of viral hepatitis 25 (9) (2018)
Minhui Dong, Jingwen Wu, Xueping Yu, Jing Li, Sisi Yang, Xun Qi, Richeng Mao, Yongmei Zhang, Jie Yu, Haoxiang Zhu, Feifei Yang, Yanli Qin, Ji-Ming Zhang
Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients. Liver international : official journal of the International Association for the Study of the Liver 38 (9) (2018)